← Leaderboards
Richard K Zimmerman
University Of Pittsburgh At Pittsburgh
$30,590,376
Attributed
$33,704,271
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$28,875,482 · 8
NIH$4,828,789 · 4
AHRQ$0 · 2
By mechanism
U01$28,875,482 · 8
R01$4,680,205 · 3
R03$148,584 · 1
P01$0 · 1
P60$0 · 1
Top collaborators
- Kenneth J Smith5 shared
- John F Alcorn4 shared
- Jishnu Das4 shared
- Harinder Singh4 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Harinder Singh$15,916,174
- Jishnu Das$5,608,209
- John F Alcorn$9,508,312
- Robbie B Mailliard$3,953,563
- Louis D Falo$30,012,458
Others in their field
Top investigators on “Vaccines”
- Lawrence Corey · Fred Hutchinson Cancer Center$829,044,908
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$556,540,832
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$515,215,260
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
- Dennis R. Burton · Scripps Research Institute$316,106,418
Research focus
VaccinesHealth Services Research TagCoupledClinical ResearchVaccinationInfluenzaPatternEffectivenessImmunityCohortInfluenza VaccinationInfluenza Virus VaccineProgramsSeasonal InfluenzaHuman SubjectImmunizationHealth Care Service UtilizationHealth BehaviorStreptococcus Pneumoniae VaccineDisease /Disorder Prevention /ControlInfluenza VaccinesBehavioral /Social Science Research TagElderlyBase
Grant awards (55)
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system$1,610,715
U01 · FY2025 · IP · contact PI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults$762,973
R01 · FY2025 · AI
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system$1,900,000
U01 · FY2024 · IP · contact PI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults$780,295
R01 · FY2024 · AI
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system$1,900,000
U01 · FY2023 · IP · contact PI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults$775,988
R01 · FY2023 · AI
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system$2,495,017
U01 · FY2022 · IP · contact PI
Uncovering latent factors underlying weak and robust responses to influenza vaccine in healthy and obese older adults$775,914
R01 · FY2022 · AI
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network$2,400,000
U01 · FY2020 · IP · contact PI
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network$1,900,000
U01 · FY2019 · IP · contact PI
Flu vaccine effectiveness in thosehospitalized in a large diverse health system$830,000
U01 · FY2019 · IP · contact PI
Flu vaccine effectiveness in those hospitalized in a large diverse health system$725,953
U01 · FY2019 · IP · contact PI
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network$500,000
U01 · FY2019 · IP · contact PI
Flu vaccine effectiveness in those hospitalized in a large diverse health system$500,000
U01 · FY2019 · IP · contact PI
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network$1,600,000
U01 · FY2018 · IP · contact PI
Flu vaccine effectiveness in those hospitalized in a large diverse health system$900,000
U01 · FY2018 · IP · contact PI
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network$300,000
U01 · FY2018 · IP · contact PI
Flu vaccine effectiveness in those hospitalized in a large diverse health system$649,797
U01 · FY2017 · IP · contact PI
Future of influenza vaccine strategies given interference and choice$394,640
R01 · FY2017 · GM · contact PI
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network$1,100,000
U01 · FY2016 · IP · contact PI
Flu vaccine effectiveness in those hospitalized in a large diverse health system$552,431
U01 · FY2016 · IP · contact PI
Future of influenza vaccine strategies given interference and choice$376,939
R01 · FY2016 · GM · contact PI
Future of influenza vaccine strategies given interference and choice$37,588
R01 · FY2016 · GM · contact PI
Flu vaccine effectiveness in those hospitalized in a large diverse health system$30,902
U01 · FY2016 · IP · contact PI
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large$1,413,786
U01 · FY2015 · IP · contact PI
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM$400,000
U01 · FY2015 · IP · contact PI
Future of influenza vaccine strategies given interference and choice$374,915
R01 · FY2015 · GM · contact PI
Flu vaccine effectiveness in those hospitalized in a large diverse health system$300,000
U01 · FY2015 · IP · contact PI
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM$72,855
U01 · FY2015 · IP · contact PI
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large$1,545,000
U01 · FY2014 · IP · contact PI
Future of influenza vaccine strategies given interference and choice$400,953
R01 · FY2014 · GM · contact PI
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM$400,000
U01 · FY2014 · IP · contact PI
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large$785,000
U01 · FY2013 · IP · contact PI
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM$400,000
U01 · FY2013 · IP · contact PI
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large$1,085,000
U01 · FY2012 · IP · contact PI
A Vaccination SOP Toolkit in Diverse Practices Implemented & Tested with RE-AIM$299,889
U01 · FY2012 · IP · contact PI
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac$259,876
U01 · FY2012 · IP · contact PI
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large$1,077,954
U01 · FY2011 · IP · contact PI
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac$260,000
U01 · FY2011 · IP · contact PI
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac$21,318
U01 · FY2011 · IP · contact PI
From Innovation to Solutions: Autodialers, Use of Early Autumn Physicals and Vac$259,989
U01 · FY2010 · IP · contact PI
Office Barries & Facilitators to Overcoming Disparities in Elderly Vaccinations$250,000
U01 · FY2006 · IP · contact PI
Influenza Vaccination of Healthcare Workers in a Diverse Hospital Network$150,000
U01 · FY2006 · IP · contact PI
Predictors of Cancer Screening in Diverse Practices$74,250
R03 · FY2005 · CA
Influenza Vaccination of Healthcare Workers in a Diverse Hospital Network$0
U01 · FY2005 · IP
Office Barries &Facilitators to Overcoming Disparities in Elderly Vaccinations$0
U01 · FY2005 · IP
Predictors of Cancer Screening in Diverse Practices$74,334
R03 · FY2004 · CA
CORE -- IMMUNIZATION AND PNEUMONIA DISPARITIES RESEARCH$0
P60 · FY2002 · MD
ELIMINATING DISDPARITIES IN ADULT IMMUNIZATION RATES$0
P01 · FY2002 · HS
ELIMINATING DISDPARITIES IN ADULT IMMUNIZATION RATES$0
P01 · FY2001 · HS
DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION$0
R01 · FY2001 · HS
DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION$0
R01 · FY2001 · HS
DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION$0
R01 · FY2000 · HS
DETERMINING/UNDERSTANDING BARRIERS TO ADULT IMMUNIZATION$0
R01 · FY2000 · HS
ELIMINATING DISDPARITIES IN ADULT IMMUNIZATION RATES$0
P01 · FY2000 · HS